A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli Lilly’s blockbuster weight-loss drug. CVS Caremark stopped covering Zepbound ...

Pharmacy benefit manager CVS Caremark decided to replace Zepbound with Wegovy for use in weight loss starting July 1, despite Zepbound users having more weight loss success. The company will no longer ...

The company’s massive pharmacy benefit manager changed its rules and weaponized audits to ensure independent pharmacies ...

A House committee found that CVS Health may have violated federal antitrust laws by threatening independent pharmacies to ...